Arcturus Therapeutics' President & CEO, Joseph Payne, Discusses COVID-19 Vaccine Candidate i24 News

preview_player
Показать описание
Joseph Payne, President and CEO, of Arcturus Therapeutics describes COVID-19 Vaccine candidate on i24 News highlighting vaccine attributes using self-replicating mRNA, vaccine class of being devoid of viruses and viral vectors, and clinical trial status.
Рекомендации по теме